Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 10, 2017

Primary Completion Date

November 1, 2022

Study Completion Date

December 1, 2025

Conditions
Gastric Cancer
Interventions
PROCEDURE

surgery

D2 gastrectomy + metastasectomy

DRUG

chemotherapy

capecitabine and oxaliplatin (eight 3-week cycles of oral capecitabine 1000 mg/m² twice daily on days 1-14 plus intravenous oxaliplatin 130 mg/m² on day 1) for 6 months or progress of disease

Trial Locations (9)

Unknown

RECRUITING

Anqing Municipal Hospital, Anqing

RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

RECRUITING

First Affiliated Hospital of Wannan Medical College, Wuhu

RECRUITING

Cancer Center of Sun Yat-sen University, Guangzhou

RECRUITING

Yuebei People's Hospital, Guangzhou

RECRUITING

Jiangxi Provincial Cancer Hospital, Nanchang

RECRUITING

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Sun Yat-sen University

OTHER